Entry points into neuroscience: A Q&A with Thomas Biederer
At the heart of all nervous system functions are the synapses, where signals fly between…
At Cell Bio 2023, a multidisciplinary panel suggests solutions for antibody validation
Antibodies are among biologists’ most essential tools, but many just don’t work. Worse, many researchers…
For IPI Board member Auro Nair, biotech is an outlet for good
Growing up in Malaysia, Auro Nair learned two basic tenets from his parents: Be a…
Dissecting the nervous system’s self-assembly toolkit: A Q&A with Alex Jaworski
Early in development, an embryo begins an epic undertaking: the building of its nervous system.…
IPI cell surface receptor research and the opioid crisis
Cell surface receptors are the root cause of a number of illnesses, and the target…
Tim Springer’s journey to IPI
Tim Springer tells his journey of becoming a bioscientist, launching a string of successful biotechs…
Jazz and a journey to biotech: Issi Rozen brings creative spirit to IPI Board
Becoming a jazz guitarist starts with a soul-catching chord. That initial spark of inspiration is…
Andreas Plückthun at IPI Surfacing: Forcing actions on surface receptors by engineered binding molecules
Andreas Plückthun speaks at IPI Surfacing, a symposium on cell surface receptor biology and protein…
Yvonne Jones at IPI Surfacing: Some structural stories from the cell surface
Yvonne Jones speaks at IPI Surfacing, a symposium on cell surface receptor biology and protein…
Junichi Takagi at IPI Surfacing: The “Lasso-grafted” Fc design platform offers creation of novel receptor agonists and antagonists
Junichi Takagi speaks at IPI Surfacing, a symposium on cell surface receptor biology and protein…
Christopher Garcia at IPI Surfacing: Modulating cell physiology through ligand-receptor engineering
Christopher Garcia speaks at IPI Surfacing, a symposium on cell surface receptor biology and protein…
IPI Surfacing panel discussion: The promise of synthetic antibodies and the challenges to universal access
The IPI Surfacing panel discusses the biomedical applications of synthetic antibodies, barriers to competing with…